Edward V. Nunes

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 681 citations · Full text

Opioid Epidemic, Comparative Effectiveness, Substance Abuse +10

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Evgeny Krupitsky, Edward V. Nunes, Walter Ling et al. · The Lancet · 2011 · 543 citations

Opioid Dependence, Injectable Extended-release Naltrexone, Substance Abuse +14

Cognitive deficits predict low treatment retention in cocaine dependent patients

Efrat Aharonovich, Deborah S. Hasin, Adam C. Brooks et al. · Drug and Alcohol Dependence · 2005 · 393 citations

Substance Abuse, Substance Use, Psychopathology +11

Effects of Major Depression on Remission and Relapse of Substance Dependence

Deborah S. Hasin, Xinhua Liu, Edward V. Nunes et al. · Archives of General Psychiatry · 2002 · 370 citations

Zero-Inflated and Hurdle Models of Count Data with Extra Zeros: Examples from an HIV-Risk Reduction Intervention Trial

Mei‐Chen Hu, Martina Pavlicová, Edward V. Nunes · The American Journal of Drug and Alcohol Abuse · 2011 · 343 citations · Full text